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Abstract
Background: The associations between cardiovascular disease (CVD) risk factors and the biventricular geometry of the
right ventricle (RV) and left ventricle (LV) have been difficult to assess, due to subtle and complex shape changes. We
sought to quantify reference RV morphology as well as biventricular variations associated with common cardiovascular
risk factors.
Methods: A biventricular shape atlas was automatically constructed using contours and landmarks from 4329 UK
Biobank cardiovascular magnetic resonance (CMR) studies. A subdivision surface geometric mesh was customized to
the contours using a diffeomorphic registration algorithm, with automatic correction of slice shifts due to differences in
breath-hold position. A reference sub-cohort was identified consisting of 630 participants with no CVD risk factors.
Morphometric scores were computed using linear regression to quantify shape variations associated with four risk
factors (high cholesterol, high blood pressure, obesity and smoking) and three disease factors (diabetes, previous
myocardial infarction and angina).
Results: The atlas construction led to an accurate representation of 3D shapes at end-diastole and end-systole, with
acceptable fitting errors between surfaces and contours (average error less than 1.5 mm). Atlas shape features had
stronger associations than traditional mass and volume measures for all factors (p < 0.005 for each). High blood
pressure was associated with outward displacement of the LV free walls, but inward displacement of the RV free wall
and thickening of the septum. Smoking was associated with a rounder RV with inward displacement of the RV free
wall and increased relative wall thickness.
Conclusion: Morphometric relationships between biventricular shape and cardiovascular risk factors in a large cohort
show complex interactions between RV and LV morphology. These can be quantified by z-scores, which can be used
to study the morphological correlates of disease.
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Background
Large epidemiological studies have established hyperten-
sion, smoking, diabetes, and hyperlipidaemia as factors
associated with increased risk of adverse cardiovascular
events [1–3]. Heart shape and function also adapt in re-
sponse to subclinical disease processes, and study of the
effects of risk factors on heart shape and function can
give insight into the mechanistic processes leading to
symptomatic disease. Although relationships between
global ventricular mass and volume have been well stud-
ied [4–6], associations with regional shape and motion
remain poorly understood. In particular, interactions be-
tween right ventricular (RV) and left ventricular (LV)
shape and function [7, 8] imply the need to study both
in combination, as changes in one ventricle are likely to
affect the other.
Atlas-based analysis can provide detailed information
on shape variations and their relationships with disease
processes. These methods have enabled robust and pre-
cise quantification of relationships between LV shape
and risk factors in the asymptomatic population [9, 10],
and remodeling after myocardial infarction [11]. LV
chamber dilatation, sphericalization and hypertrophy
have also been associated with obesity [12] and hyper-
tension [13]. However, changes in RV geometry and
function are also important in many cardiovascular dis-
eases [14–17] but are less well understood due to the
complex shape of the chamber.
The goal of this study was to establish a reference
healthy morphology, and investigate the RV variations
and biventricular interactions associated with common
risk factors using a biventricular atlas. We developed an
automated framework to customize a 3D subdivision
surface mesh to contour and landmark positions manu-
ally defined at end-diastole (ED) and end-systole (ES) in
over 4000 participants of the UK Biobank cardiovascular
magnetic resonance (CMR) imaging extension. The atlas
captured the shape and motion of both LV and RV as
well as the mitral and tricuspid valves’ positions and orien-
tations. The strength of associations between biventricular
shape and cardiovascular risk factors and disease were
evaluated by computing morphological scores using logis-
tic regression analysis. This enabled characterization of
the RV variation as well as biventricular interactions
associated with each risk factor.
Methods
Study population
We assessed CMR examinations and data from the first
4989 participants obtained from the UK Biobank. The
UK Biobank study is a large prospective study designed
to identify the causes of complex diseases by collecting
questionnaire data, physical measurements and bio-
logical samples from 500,000 individuals in the UK [18].
In 2015, the UK Biobank extended their study into
imaging, including brain, heart, whole body composition,
carotid artery, bone and joint imaging, with the aim to
scan 100,000 participants by 2023. All participants gave
written informed consent and the appropriate institutional
review boards approved the study protocol (National
Research Ethics Service North West 11/NW/0382).
CMR imaging protocol and image analysis
The UKB CMR protocol has been described previously
[19]. Briefly, all imaging was performed on a wide bore
1.5 T scanner (MAGNETOM Aera, Syngo Platform
VD13A, Siemens Healthineers, Erlangen, Germany)
using a phased-array cardiac coil. Retrospectively gated
balanced steady state free precession cine images were
acquired with three long axis orientations (horizontal
long axis, vertical long axis, LV outflow tract) and a
complete short axis stack covering both the RV and the
LV (6 mm thickness for long axis, 8 mm thickness for
short axis, flip angle 80°, TR/TE = 2.6.1.1 ms, temporal
resolution 32 ms interpolated to 50 phases per cardiac
cycle, pixel size 1.8 × 1.8 mm). Each slice was acquired in
a separate breath-hold.
Contours and landmarks were defined manually by eight
observers independently across two core-laboratories using
cvi42 post-processing software (Version 5.1.1, Circle
Cardiovascular Imaging Inc., Calgary, Canada) [20]. Inter-
observer variabilities have been reported previously [20]
with intra-class correlation coefficient 0.97 for LV end-
diastolic volume (EDV), 0.88 for LV end-systolic volume
(ESV), 0.92 for RVEDV and 0.77 for RVESV. RV and LV
endocardial borders, LV epicardial borders, and left and
right atrial endocardial borders were drawn at both ED
and ES in accordance with the Society for Cardiovascular
Magnetic Resonance recommendations [21]. The ED
frame was selected as the first frame after detection of the
R wave, and the ES frame was selected as the smallest LV
blood pool area in the mid-ventricular slice. At both ED
and ES, the most basal slice had at least 50% of the LV
blood pool surrounded by myocardium. LV papillary mus-
cles were excluded from the LV mass but included as part
of the LV ED volume to reduce inter-observer variability.
Tricuspid and mitral valves points were defined from left
atrial contours delineated on the two-chamber and four-
chamber long axis images, and right atrial contours on the
four-chamber long axis images.
Cardiovascular disease risk factors and reference healthy
group
Four preclinical cardiovascular disease (CVD) risk fac-
tors: high cholesterol, smoking, high blood pressure, and
obesity, were selected for the analysis based on previous
studies [6]. Three disease factors, presence of diabetes,
previous angina and previous myocardial infarction
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(MI), were also examined. All factors were categorised as
dichotomous variables. Smoking status was defined as
self-reported current smoker vs non-smoker at the time
of CMR examination. Diabetes and high cholesterol were
determined by participants’ answers to binary question-
naire items: e.g. diabetes diagnosed by a doctor, diagnosis
of high cholesterol, or use of medication for cholesterol.
Obesity was defined as body mass index (BMI) more than
30 kg/m2. Previous MI or angina were determined by
participant self-reporting, including previous diagnosis by
a doctor or current use of medications.
In [20], a sub-cohort from the same UK Biobank partici-
pants was determined by excluding participants > 74 years,
known CVD or symptoms of disease, and other conditions
or medications relating to conditions known to affect car-
diac chamber size and function. Due to the small number
of non-Caucasian participants, these were also excluded.
In this study, we applied the same criteria, and also ex-
cluded any participants with high blood pressure or any of
the risk factors and diseases defined above as recorded on
the same visit as the CMR scan, to define the reference
healthy group. Further details of exclusion criteria are
given in Petersen et al. [20].
Cases without adequate information on risk factors, or
adequate RV endocardial contours, valve points or apical
points to form a biventricular geometry, were excluded
from our study, leaving 4329 cases included in the atlas.
After all exclusions, 630 cases were included in the refer-
ence group. Characteristics of the participants included,
and the reference group, are shown in Table 1.
Patient-specific biventricular surface mesh
A biventricular subdivision surface template mesh was
constructed as described previously in [22]. This
included the LV, RV, and the four valves (aortic, mitral,
tricuspid and pulmonary). The coarse mesh comprised a
total of 182 hexahedral elements with 388 vertices. To
generate a smooth surface mesh, this coarse mesh was
then subdivided twice using the Catmull-Clark algorithm
[23, 24]. Figure 1 shows the template coarse mesh (top
row) and the final smooth surface mesh (bottom row).
The final surface mesh consisted of 5352 unique vertices.
During the subdivision process, sharp edges [25] were
maintained at the RV insertions and the four valves.
The epicardium of the RV free wall was not manually
contoured, however the biventricular epicardium was
required to customize the surface mesh. Therefore, we
estimated the RV epicardial mesh points by extending
the RV endocardium mesh points by a fixed distance
perpendicular to the endocardial surface, determined by an
average RV wall thickness for ED (3mm) and ES (5mm)
[26]. Note that the RV epicardium was only used to
complete the biventricular model during the fitting, but
was not included in subsequent analyses.
Figure 2 shows the automated biventricular atlas con-
struction pipeline, where contours were the input. Patient-
specific biventricular mesh customization was performed
in two steps: 1) correction of breath-hold misregistration
between short-axis slices, and 2) deformation of the subdi-
vided template mesh to fit the manual contours while pre-
serving the topology of the mesh. To correct breath-hold
misregistration, we adapted the method described previ-
ously in [9]. Briefly, a stiff linear least squares optimization
was performed only on the LV with the long-axis images
using the D-Affine regularization method [27]. Next, 2D
Table 1 Characteristics of the participants included in the atlas,
and the reference healthy sub-cohort. The data are presented as
mean ± std. dev. or number of positives (% of total). MI,
myocardial infarction
Total Reference healthy sub-cohort
n 4329 630
Age (years) 62.0 ± 7.5 59.1 ± 6.3
Male 2057 (48%) 290 (46%)
Weight (kg) 75.8 ± 15.3 69.2 ± 11.7
Height (cm) 169.8 ± 9.4 169.9 ± 8.1
Smoking 280 (6%) 0
High cholesterol 294 (7%) 0
Previous MI 93 (2%) 0
Diabetes 223 (5%) 0
Angina 101 (2%) 0
High blood pressure 1125 (26%) 0
Obesity 709 (16%) 0
Fig. 1 Biventricular coarse mesh (left) and its Catmull Clark subdivision
at level 2 (right). The left ventricle (LV) is shown in green, the right
ventricle (RV) in blue and the epicardium in red. The mitral valve is
highlighted in cyan, the aortic valve in yellow, the tricuspid valve in
magenta and the pulmonary valve in green
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contour intersections between the surfaces and short axis
slices were generated, and the centre of each contour was
calculated by using the area-weighted average of the bary-
centre defined by the area of the intersected contour. The
longitudinal line that aligns with these centres was deter-
mined as the new centre to shift the short axis images so
that the contour barycentre aligned with the new centre.
Contours were shifted in two directions within the image
plane (in-plane). This breath-hold misregistration correc-
tion process was applied to all short-axis slices.
After correcting for the slice misregistration, the coarse
mesh was customized to each case using a diffeomorphic
registration algorithm that deforms the surfaces while
preserving the topology of the heart [22]. Briefly, the
algorithm consists of two iterative processes: 1) a linear
least-squares optimization, which provides an initial solu-
tion close to the contours, 2) a non-linear optimization
process with explicit diffeomorphic constraints to avoid
epicardial and endocardial surface intersection.
Two quality metrics were used to assess the quality of
a patient-specific biventricular mesh: 1) global point-to-
surface distances between the manual contour points
and the customized mesh, and 2) cardiac volume com-
parisons between the customized mesh and the manual
contours, including EDV, ESV, stroke volume (SV), and
ejection fraction (EF) of both ventricles. The first metric
gives information on the surface errors and the second
metric quantifies volume errors using the standard slice
summation method as a reference.
Biventricular atlas
To build the biventricular atlas, all the ED mesh points
were first aligned by a rigid registration of translation
and rotation using the Procrustes algorithm. This trans-
formation was then applied to the ES mesh. ED and ES
surface points were then concatenated to form a long
vector. Principal component analysis (PCA) was subse-
quently performed on the NxP matrix, where N = 4329
is the number of subjects and P = 32,112 is the number
of ED and ES 3D (x,y,z) vertex coordinates. PCA com-
putes the principal components of shape variation across
the cohort, ordered by amount of variance explained
[28]. Using a concatenation of ED and ES shapes instead
of ED or ES alone captures the variation in function
(motion between ED and ES) as well as shape in the
statistical atlas. Pulmonary and aortic valve points, and
RV free wall epicardial points were removed from the
surface meshes prior to PCA, since data on these areas
were not available in the manual contours.
Strength of geometric relationships
In order to quantify the strength of the relationships be-
tween the biventricular shapes and the risk factors, we
constructed regression models using penalised logistic
regression with elastic net regularization [29]. Briefly, this
method optimizes the logistic function and penalizes both
the absolute value of the coefficients, in order to shrink
irrelevant coefficients to zero, and the squared size of the
coefficients, to limit the impact of collinearity.
For each risk factor, a separate regression model was
built using that factor as the univariate dependent vari-
able, and the PCA component scores as the independent
variables. Participants with positive coding for the risk
factor were selected as positives, and participants in the
reference healthy group were selected as negatives. Any
participants who also had previous MI and angina were
removed from the positives. For angina, only partici-
pants who were positive for previous MI were removed.
For previous MI, no participants were removed.
Receiver operating characteristic (ROC) and precision
recall (PR) curves were generated to quantify the
strength of relationships in the presence of imbalanced
classes (number of positives being typically less than the
number of negatives) [30, 31]. An area under the ROC
curve (AUC) of 0.5 suggested no discrimination (50%
chance of distinguishing positive from negative cases),
0.7 to 0.8 was acceptable, 0.8–0.9 was excellent and > 0.9
was outstanding [32]. To calculate optimal performance,
a cut-off value was calculated using the Youden index
[33], maximizing both specificity and sensitivity values.
The above shape regression models were compared with
a baseline model constructed using LVEDV, RVEDV,
Fig. 2 Atlas construction pipeline: a 3D contour points extracted from 2D contour points. Mitral points are shown in blue and tricuspid points in
red. b Registration framework. c Registration results. d Principal component analysis of shape variation. Upper and lower panel show ±2 std. dev
in the fourth mode at end-diastole (ED)
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LVESV, RVESV, and LV mass (LVM) as independent vari-
ables. For these comparisons the covariates of age, sex,
height and weight were not included as independent
variables as they obscured the strength of associations
with geometric factors alone. As above, a ten-fold cross-
validation was performed. For each fold, the average ROC
(aROC) and average PR (aPR) for the test sets across the
ten folds were calculated for each risk factor and the
average specificity, sensitivity (or recall), precision (or
positive predictive value), F1-score, AUC and cut-off
values were calculated.
Morphometric associations with risk factors
Associations between the biventricular shape and risk fac-
tors were examined further using multiple linear regres-
sion. In this multivariate model, the PCA component
scores were treated as the dependent variables and the in-
dependent variables comprised age, sex, height and pres-
ence of the risk and disease factors. A morphometric
mode was estimated for each risk factor and disease vari-
able, by partitioning the contribution of each factor to the
shape. From this morphometric mode, a score can be
automatically calculated and standardized to produce
morphometric scores. The visualizations and scores are
therefore corrected for confounding factors such as age,
sex and height, as well as the presence of multiple risk fac-
tors and the presence of disease (see Appendix for details).
In addition to the morphometric scores and shape
modes, traditional measures such as volume and dimen-
sions could be calculated from the morphometric shapes
for each factor. These included EDV, ESV, EF, LVM, RV
longitudinal shortening, RV eccentricity, RV sphericity,
LV relative wall thickness, and LV mass-to-volume ratio.
RV longitudinal shortening was computed as the change
in length from the middle of the tricuspid valve to the
RV apex between ED and ES divided by the length at
ED. RV sphericity was defined as the ratio between the
base-apex length and the perpendicular distance be-
tween the RV free wall and the septum. RV eccentricity
was calculated as the ratio of the minor axis parallel to
the septum divided by the minor axis perpendicular to
the septum [34]. The eccentricity index was calculated
as the ratio of the LV minor axis parallel to the septum
divided by the LV minor axis perpendicular to the
septum [35]. LV sphericity was calculated as the EDV di-
vided by the volume of a sphere with a diameter corre-
sponding to the LV major axis at ED in the long axis
four chamber view [36]. The LV relative wall thickness
Fig. 3 Bland-Altman agreement plots between biventricular mesh fitting and manual analysis. a LV end-diastolic volume index, b LV end-systolic
index, c RV end-diastolic index, and d RV end-systolic index. Mean biases and ± 2 std. dev of measurement differences are shown as horizontal
dashed lines. LV = left ventricle. RV = right ventricle
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was defined as twice the posterior wall thickness divided
by the ED diameter.
Statistical analysis
Statistical evaluation was carried with R [37] and the caret
package (http://caret.r-forge.r-project.org/). ROC and PR
curves were generated using the pROC package [38]. Sig-
nificant differences between ROC curves were calculated
using DeLong’s test on the average ROC, available from
the pROC package. Two-tailed paired t-tests of cardiac
volumes measured between the automated methods with
manual contours were performed. P values of < 0.005 were
considered as statistically significant.
Results
Patient-specific biventricular mesh
The biventricular mesh template was successfully custom-
ized to all cases using the fully automatic process (Fig. 2).
RV and LV volumes calculated from the mesh using nu-
merical integration agreed well with the volume computed
from manual contours using standard slice summation. RV
EDV and ESV biases were and − 6.0 ± 9.4ml (p < 0.005)
and 1.6 ± 6.3ml (p < 0.005) respectively. LVEDV and ESV
biases were− 2.6 ± 11.3ml (p < 0.005) and − 5.2 ± 8.2ml
(p < 0.005) respectively. Figure 3 shows the Bland-Altman
agreement plots of the LV and RV volumes between the
biventricular mesh with manual contours. The average
point-to-surface distances between the contour points and
the customized mesh surfaces were less than 2mm. For the
RV endocardium, the distances were 1.5 ± 0.9mm, for the
LV endocardium were 1.2 ± 0.7mm and for the epicardium
were 1.3 ± 0.8mm. The average in-plane translation for
breath-hold misregistration correction was 2.8 ± 1.5mm,
consistent with previous results [9, 39].
Atlas principal components
Figure 4 visualizes the first four principal components of the
biventricular shape variations by showing the shapes at ±2
standard deviation from the average shape. Animations of
these components can be seen in the Additional file 1:
Figure S2. These first four modes represent the biggest
variations of the LV and RV shapes across the 4329 cases.
Additionally, since ED and ES shapes were concatenated in
the PCA calculation, Fig. 4 also visualizes variations in mo-
tion between ED and ES frames. The biggest variation with
30.2% (Mode 1) was associated with the size of the heart.
The second mode (9.8%) shows differences in the motion
of the tricuspid valve (red arrow), which can be associated
with the tricuspid annular plane systolic excursion
(TAPSE). The third (7.4%) and fourth (5.1%) modes were
visually associated with the height to width ratio (spher-
icity) of the ventricles, and the base orientation, respect-
ively. The first 50 PCA modes accounted for 92.1% of the
total shape variance. Figure 5 shows the percentage of
variance explained as a function of mode number.
Strength of geometric relationships
Table 2 shows the results of the cross-validation logistic
regression models for the shape atlas, comparing a
model using the first 50 PCA modes (PCA50), with a
baseline model using standard mass and volumes as in-
dependent variables (MassVol). In general, the PCA50
models showed higher sensitivity (recall), specificity, pre-
cision (positive predictive value), F1-score (a harmonic
average of precision and recall) and negative predictive
value at the Youden cutoff. Using the DeLong test, the
PCA50 models showed significantly higher AUC than
the standard MassVol model for previous MI, high chol-
esterol, smoking, diabetes, obesity, angina, and high
blood pressure. ROC and PR curves are shown in Fig. 6.
All PCA50 PR curves were above the corresponding
MassVol curves, showing a higher precision for each
value of recall than the MassVol models. For the PCA50,
angina, smoking, high blood pressure, and high
Fig. 4 First four components of variation for the combined end-diastole
(ED) and end-systole (ES) atlas. The ED is shown in wireframe and the ES
in solid mesh. The right ventricle is shown in blue, the LV in green and
the LV epicardium in red. The mitral valve is shown in pink and the
tricuspid valve in yellow. The red arrow shows changes in the motion of
the tricuspid valve. The left and right shapes of each mode correspond
to the mean ± 2 std. dev. Animations of these shape components have
been provided in the Additional file 1: Figure S2
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cholesterol regression models showed an acceptable
AUC. Presence of diabetes, previous MI and obesity
showed an excellent AUC. For MassVol, only the previ-
ous MI regression model showed an acceptable AUC.
Morphometric associations with risk factors
Morphometric scores and shape modes were calculated
using a multivariate regression model with the first 50
PCA modes as dependent variables, and age, sex, height,
risk factors and disease factors as independent variables,
as detailed in the Appendix. Significant effects were
found for several risk factors for specific principal com-
ponents. The first principal component (associated with
size) was significantly increased with high blood pres-
sure, obesity, and previous MI and decreased in diabetes
and high cholesterol. The second principal component
(associated with TAPSE) was significantly decreased with
smoking, high blood pressure and obesity as well as dia-
betes, previous MI and angina. The third principal com-
ponent (associated with sphericity) was significantly
increased with obesity and previous MI. Figure 7 shows
average morphometric shape changes associated with
high blood pressure (Fig. 7a) and smoking (Fig. 7b). Red
colours refer to change of position outward from the LV
or RV free wall, and for the septum outward from the
LV (inward to the RV), relative to the mean. High blood
pressure was associated with an outward displacement of
the LV free wall and an inward displacement of the LV side
of the septum at ES, together with an outward displace-
ment of the RV side of the septum (towards the RV)
resulting in a thickening of the septum and contributing
to the decreased RVESV. For smoking, regional shape
Fig. 5 Percentage of variance explained as a function of mode for the atlas
Table 2 Ten-fold cross-validation results from penalized logistic regression models using the first 50 PCA modes (PCA50) and from
the reference baseline mass/volumes (MassVol) measurement models
Factor Model AUC Sensitivity Specificity Precision F1-score npv Cutoff
Cholesterol MassVol 0.587 0.704 0.451 0.346 0.464 0.787 0.495
PCA50* 0.751 0.792 0.579 0.437 0.564 0.871 0.485
Smoking MassVol 0.594 0.856 0.287 0.334 0.480 0.826 0.490
PCA50* 0.699 0.525 0.795 0.517 0.521 0.800 0.511
Diabetes MassVol 0.652 0.740 0.554 0.342 0.468 0.872 0.494
PCA50* 0.817 0.704 0.781 0.502 0.586 0.894 0.504
Previous MI MassVol 0.733 0.699 0.663 0.235 0.351 0.937 0.490
PCA50* 0.853 0.677 0.911 0.529 0.594 0.950 0.518
Angina MassVol 0.671 0.700 0.637 0.196 0.307 0.944 0.497
PCA50* 0.773 0.663 0.763 0.262 0.376 0.947 0.493
Obesity MassVol 0.682 0.675 0.598 0.638 0.656 0.637 0.494
PCA50* 0.839 0.760 0.763 0.771 0.766 0.752 0.500
Hypertension MassVol 0.651 0.693 0.543 0.718 0.705 0.514 0.495
PCA50* 0.770 0.752 0.663 0.789 0.770 0.615 0.494
Statistical tests were performed between MassVol and PCA50. Significant differences (p < 0.005) are represented with an asterisk
PCA principal component analysis, MI myocardial infarction
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changes were found in both RV and LV. The septum
shifted rightwards at ES while most of the free walls
moved inward, except for regions around the valves. Visu-
alizations of the changes associated with the other risk fac-
tors can be found in the online Additional file 2: Figure
S1. As a comparison, changes associated with age and sex
(Additional file 2: Figure S1) show that males had larger
ventricles and older people had relatively smaller ventri-
cles, as found previously [6, 40, 41].
Table 3 shows how the volumes and dimensions de-
rived from average shapes in each class change with each
risk or disease factor. Percentage change corresponds to
the difference between the mean shape for the negatives
and the mean shape for the positives for each factor.
Smoking was associated with shapes with lower vol-
umes, higher RV eccentricity and lower RV shortening,
and higher LV mass to volume ratio and relative wall
thickness. High cholesterol was associated with lower
volumes and mass, smaller RV shortening and higher LV
sphericity. High blood pressure was associated with
smaller RV and greater LV volumes, higher RV
shortening and smaller RV eccentricity and sphericity,
along with higher LV mass to volume ratio and relative
wall thickness. Obesity was associated with greater RV
and LV volumes, greater RV sphericity and smaller RV
shortening and eccentricity, and increased LV mass to
volume ratio and relative wall thickness. Diabetes was
associated with lower RV and LV volumes, but higher LV
mass to volume ratio. Previous MI was associated with
increased RV and LV volumes, increased RV shortening
and RV eccentricity, decreased LV mass to volume ratio,
and decreased LV shortening.
Discussion
There are limited data on the morphological changes as-
sociated with risk factors in the general population. This
study provided a direct comparison of relationships be-
tween RV and LV geometry and motion and common
risk factors and disease. Analysis of both ventricles is
motivated by the anatomical coupling of a continuous
system of muscle fibers, a common septal wall, and en-
closure within the pericardium [42]. Both acute and
Fig. 6 Receiver Operating Characteristics (ROC) curves and Precision-Recall curves for each risk factor regression model. MassVol and PCA50
models are shown by red and blue curves, respectively
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Fig. 7 Shape changes due to high blood pressure (a) and smoking (b), adjusted for age, sex, height and other factors. Colors denote difference
from the mean shape in mm (red outward, blue inward) for factor positive (Positive) and factor negative (Negative) groups. Outward directions
are shown on the top right picture. Top row: anterior view of the RV (left) and LV (right). Bottom row: posterior view (left: LV, right: RV).
Histograms show morphometric scores for reference healthy group and factor positive group
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chronic interactions have been observed previously [43].
Here, we found that shape scores had stronger relation-
ships with risk factors and disease than traditional mass
and volume measures. The contributions of each factor,
corrected for the presence of other factors and age, sex, and
height, could be quantified, visualized and expressed as a
morphometric score. The atlas shape features incorporated
both ED and ES shape and the motion between, with many
factors associated with changes in contraction patterns.
In this study, the principal component explaining the
most variation of biventricular shape was associated with
the size, as found in previous studies [9, 44]. We found
significant increases in size due to high blood pressure
and previous MI but decreases due to diabetes and chol-
esterol. The decrease in size found in patients with high
cholesterol may be due to medication use since statins
are known to reduce heart size. The second mode was
associated with the tricuspid valve motion. The finding
that this mode accounted for the most shape variation
after heart size is particularly striking since previous at-
lases constructed using only LV contours found that
sphericity was the second mode after size, not valve ex-
cursion [10]. Previous CMR RV atlases [44–46] did not
show this variation as mitral and tricuspid valve points
were not included. TAPSE is known to be a sensitive
index with prognostic value [47]. We found reductions
in longitudinal shortening with smoking, and obesity as
well as diabetes. The third mode was associated with
width to height ratio (sphericity) of both ventricles. Pre-
vious LV atlases found sphericity to be an important
shape feature [9, 10]. Sphericity is known to be associ-
ated with adverse remodelling process in asymptomatic
populations and patient with CVD [48]. In our study,
increases in RV sphericity mode were found with obesity
and angina.
The results of this study are in accordance with previ-
ous studies of mass and volume changes [6, 13, 49] and
extend these findings to the visualization of regional
changes for common cardiovascular risk factors. In the
Multi-Ethnic Study of Atherosclerosis (MESA), high
blood pressure and obesity were associated with larger
RV volume, and smoking and diabetes with reduced RV
volume [4, 5]. This agrees with the changes in biventri-
cular shape shown in Table 3. Males were also found to
have larger RV volumes than females (corrected for body
habitus) and a cohort effect of reduced RV volume in
older participants [40], both of which were seen in the
morphometric modes (Additional file 2: Figure S1). In
the UK Biobank, obesity and high blood pressure were
associated with increased RV volumes, whereas presence
of diabetes or high cholesterol resulted in smaller vol-
umes [6], in agreement with Table 3. The finding of in-
creased RV longitudinal shortening after previous MI in
the face of decreased LV shortening may reflect RV com-
pensation to counter the decreased LV function [50], or
increased RV preload [51].
The morphometric scores may therefore have prog-
nostic significance. In the LV, geometrical variations in-
cluding wall thickness and sphericity have been shown
to be determinants of functional mitral regurgitation
after myocardial infarction [52] and decreased survival
in heart failure [53]. Both excessively high and low
sphericity were associated with adverse outcomes in
MESA [49]. In the RV, hypertrophy was associated with
higher risk of heart failure or death in MESA [14]. In
pulmonary hypertension, LV increased eccentricity, or
Table 3 Volume and dimension differences (%) between the positive and negative means generated from each of the linear
regression morphometric modes
Smoking Chol Previous MI Diabetes Angina HBP Obesity
RV EDV −3.1 −1.5 4.2 −3.4 0.7 −0.1 8.5
RV ESV −1.7 −2.1 4.3 −2.6 −1.1 −2.4 10.1
RV Eccen. 0.514 −0.77 3.91 −0.58 − 0.38 − 0.89 − 0.72
RV Spher. − 0.08 1.2 0.04 − 0.24 0.77 −0.33 1.21
RV Short. −1.74 − 1.8 2.19 −0.02 1.85 1.84 −1.36
LV EDV −1.7 −2.2 11.7 −3.3 1.6 1.4 7.3
LV ESV 0.6 −4.2 18.4 −2.5 0.8 1.0 7.8
LV Mass −0.5 −3.1 5.4 −1.3 1.7 5.1 13.9
LV MVR 1.2 −0.8 −7.1 1.9 0.1 3.7 7.1
LV RWT 1.1 −0.7 −5.8 1.2 0.1 3.1 6.4
LV Eccen. −0.07 0.2 0.02 0.6 0.1 0.9 1.4
LV Spher. −0.2 −0.2 8.4 0.1 1.0 −1 2.1
LV Short. −0.9 0.8 −3.6 0.2 1.8 0.8 −0.1
EDV end-diastolic volume, ESV end-systolic volume, Eccen. eccentricity, Spher. sphericity, Short longitudinal shortening, LV MVR left ventricular mass to volume
ratio, LV RWT left ventricular relative wall thickness
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roundness of the ventricle, was found to be predictive of
adverse remodelling [15].
The availability of large scale CMR datasets has facili-
tated the utility of cardiac atlases. Bai et al. [44] used 1093
3D cine CMR studies of healthy subjects to build a 3D
biventricular atlas. In a study of patients with severe pul-
monary hypertension [17], RV statistical shape atlas fea-
tures were used to predict survival with better
performance than traditional mass and volume measures.
McLeod et al. [54] have also found statistical shape
variations related to arrhythmogenic right ventricular car-
diomyopathy. Compared with our previous evaluation of
LV atlases in a similar cohort [10], the biventricular ana-
lysis showed consistently higher AUC in Table 2, which
suggests that incorporating the RV geometry improves the
strengths of relationships with risk factors and disease.
One of the limitations of this study was the requirement
for initial manual contouring. Machine learning methods
are showing promise in registration and segmentation appli-
cations [55], and these will facilitate construction of highly
reproducible shape models in the future. Another limitation
of the study lies in the use of questionnaires and self-
reporting of the participant. Also, neither blood cholesterol
nor glucose data were available at this time and are therefore
based on medication and self-reporting only in this study. It
is well known that high cholesterol is associated with in-
creased volumes and that statin medications decrease vol-
umes [56]. Our findings might be therefore be confounded
by medication use. With more cases becoming available in
UK Biobank, it will be possible to examine the effects of
each risk factor independently in more detail in the future.
These would include evaluation of non-linear effects.
Conclusions
In conclusion, RV shape and function could be quantified
by atlas-based morphometric scores. Biventricular shape
features had stronger associations with common risk fac-
tors than traditional measures of mass and volume. Shape
changes associated with particular factors such as diabetes,
affecting both the RV and LV, could be quantified using
morphometric scores. These methods enable simple
characterization of complex RV shape changes as well as
biventricular interactions associated with pre-clinical dis-
ease processes. Each morphometric score can be calculated
automatically as a single z-score value, which can be simply
presented in a clinical report showing current status of a
particular patient against a reference cohort, or longitudinal
changes from previous exam. The biventricular atlas data
used in this study is available from UK Biobank on request.
Appendix
The shape models were assembled into a data matrix X
with N rows (cases) and P columns (3D surface points),
and centered by subtracting the mean. The PCA shape
modes Φ consisted of 50 columns each with P rows, com-
prising the principal component modes. The component
scores were calculated by projecting shapes onto the modes
as T =XΦ. A multivariate linear regression was used to es-
timate the contribution of each risk factor to the shape
component scores, as follows.
T ¼ A Bþ R
where T are the PCA scores, B is the matrix of regression co-
efficients, and R is a matrix of residuals. A is the matrix of
predictor variables, including age and height as continuous
variables, and sex, high cholesterol, high blood pressure,
obesity, smoking, diabetes, previous MI and angina as cat-
egorical variables. For the ith variable in A, the outer product
of the ith column of A and the ith row of B gives the contri-
bution of that variable to the estimated shape scores:
Ti
est ¼ Ai  Bi
The corresponding shapes can be calculated as.
Xi
est ¼ Tiest ΦΤ
The average predicted shapes for the positive and
negative cases for that predictor variable can be calcu-
lated as Xi
+ and Xi
− respectively. A morphometric mode
can then be calculated as.
Di ¼ Xiþ−Xi−ð Þ
and normalized to have unit length. Morphometric
scores can be calculated as.
Si ¼ DiTX
Additional files
Additional file 1: Figure S2. Animations of the first four PCA
components. (PPTX 2780 kb)
Additional file 2: Figure S1. Shape changes due to (a) previous MI, (b)
angina, (c) obesity, (d) diabetes, (e) high cholesterol, (f) sex and (h) age,
adjusted for other factors. Colors denote difference from the mean shape
in mm (red outward, blue inward) for factor positive (Positive) and factor
negative (Negative) groups. Outward directions are shown on the top
right picture. Top row: anterior view of the RV (left) and LV (right).
Bottom row: posterior view (left: LV, right: RV). Histograms show
morphometric scores for reference healthy group and factor positive
group. (PPTX 8496 kb)
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